Last updated on December 2018

Allergy to Neuromuscular Blocking Agents and Pholcodine Exposure


Brief description of study

The main objective of this study is to compare pholcodine exposure in patients having presented with a perianaesthetic anaphylactic reaction to a NMBA (cases) to pholcodine exposure in matched anaesthetised patients with injection of NMBA, who did not present with an anaphylactic reaction (controls).

The secondary objectives of the study are:

  • To compare anti-pholcodine IgE, anti-ammonium IV IgE and total IgE levels between the case and control groups.
  • To study the concordance between exposure to pholcodine in cases and controls, by means of a patient self-questionnaire on the one hand and, on the other hand, by a computerized drug history, supplemented where relevant by the drug master file.
  • To study the impact of taking 1, 2 or 3 sources in account for pholcodine exposition.
  • To study the association between exposure to pholcodine and the presence/levels of pholcodine-specific IgE, reflecting sensitisation to pholcodine.
  • To study NMBA and pholcodine cross-sensitisation by testing skin reactions to pholcodine in case patients allergic to (at least) one NMBA.

Clinical Study Identifier: NCT02250729

Contact Investigators or Research Sites near you

Start Over

Maryline Bordes

CHU de Bordeaux
Bordeaux, France
  Connect »

Omar OUTTAS, MD

CHU de Clermont-Ferrand
Clermont- Ferrand, France
  Connect »

Sandrine SELTZER, MD

CHU de Dijon
Dijon, France
  Connect »

FACON Alain, MD

CHRU de Lille
Lille, France
  Connect »

Isabelle ORSEL, MD

CHU de Limoges
Limoges, France
  Connect »

Gérard AUDIBERT, MD-PHD

CHRU de Nancy
Nancy, France
  Connect »

Sylvie LEROY, MD

CHU de Nice
Nice, France
  Connect »

Dan LONGROIS, MD- PHD

AP-HP- H pital Bichat
Paris, France
  Connect »

Marion VERDAGUER, MD

CHU de Poitiers
Poitiers, France
  Connect »

Jean-Marc MALINVOSKY, MD-PHD

CHU de Reims
Reims, France
  Connect »

Yannick MEUNIER, MD

CHU de Rouen
Rouen, France
  Connect »

Charles DZVIGA, MD

CHU de Saint Etienne
Saint- Etienne, France
  Connect »

Fréderic DE BLAY, MD- PHD

CHU de Strasbourg
Strasbourg, France
  Connect »

Alain DIDIER, MD-PHD

CHU de Toulouse
Toulouse, France
  Connect »

Pascal GIRARDIN, MD

CHU de Besan on
Besançon, France
  Connect »

Vincent PIRIOU, MD

Hospices Civils de Lyon
Pierre-Bénite, France
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.